Content
Amphetamines are strong stimulants that are used to medically treat such disorders as narcolepsy and ADHD. When abused there are a number of side effects that can occur. The side effects experienced depend upon the individual and the amount of time the substance has been used. As amphetamines are a prescription drug, many people underestimate their strength and addictive qualities. Because it produces a strong high, users often want to take more of the drug to prolong the effects.
Irrespective of the promise of pharmacotherapy, effective treatment of substance use disorders requires comprehensive biopsychosocial intervention. Nearly a quarter of the reviewed studies had no female participants, and male sex made up over 70% of the population across all studies. In nine of the studies reviewed here (20.9%), women were excluded by design. In some cases, this was due to the setting (e.g. male-only residential treatment centres), or studies conducted in specific populations (e.g. men who have sex with men), and in others the reason is not clearly stated. Research suggests women who take stimulants are more likely to become dependent consumers than men who take stimulants [77].
Future research should address small sample sizes and low participant retention and treatment adherence rates, leading to underpowered studies lacking meaningful results. Medication adherence also needs to be better examined and monitored in trials, particularly when using medications with abuse liability (e.g. psychoactive medications such as stimulants). Finally, because of the similarities in chemical structure and behavioural, psychological how long do amphetamines stay in your system and physical effects of AMPH and MA [84], we have included studies of AMPH and MA, and studies that did not distinguish between AMPH and MA. MA and AMPH may be knowingly or unknowingly consumed or co-consumed in uncertain concentrations, with variability over time and place. However, there is little data on which to assess whether there are distinct differences in use disorders due to these two substances; further assessment is required.
Thirty-four (79.1%) of the studies we reviewed excluded participants with depression or psychotic disorders, or those taking an antidepressant or antipsychotic medication. Misuse of prescription drugs, including amphetamines, can lead to addiction. The proper name for addiction to a substance is substance use disorder (SUD). Similar to cocaine treatment, agonist therapy is available for amphetamine addiction. Research has shown that use of d-Amphetamine generally leads to a decrease in drug use, injecting behavior, and dependence severity. Medications like bupropion, however, appear to having less potential for abuse than other opioid agonists, while still having the potential to reduce their use in amphetamine-dependent patients.
Some drugs react poorly with amphetamines and produce a toxic effect on the nerves. Speak with a doctor before using two or more drugs at the same time. Amphetamines can usually look like small, dark- or light-blue tablets. A 5 mg pill — which is light blue — says “M A5” to denote the formula. These drugs are used for symptoms of ADHD because they increase a person’s focus and attention. Since the drugs “wake up” the brain, they can sometimes help people counter narcolepsy issues.
Prescription pills and capsules come in various shapes and colors according to brand. People who are in recovery have a higher chance of using substances again. Recurrence can happen even years after you last took the substance. Participating in self-help programs, like Narcotics Anonymous, can also play a significant role in SUD treatment. This can create an unhealthy drive to seek more pleasure from the substance and less from more healthy experiences.
The exclusion of relatively common comorbidities such as polydrug dependence and mental health comorbidities limits the generalisability of many of the studies. For example, the role of antipsychotic and antidepressant medications may differ in patients presenting with psychosis or depression. Similarly, dependence to other substances such as alcohol, benzodiazepines or opioids is also likely to impact upon the safety and efficacy and choice of medications. Other comorbidities that continue to be poorly addressed include the management of patients with stimulant dependence and comorbid attention-deficit hyperactivity disorder (ADHD). Accurate diagnoses of ADHD in the context of AMPH/MA use can be complicated [82], and there may be differential effects of medications in patients with both conditions. More research is required regarding pharmacological responses for patients with ADHD and stimulant use disorders.
Adderall (amphetamine and dextroamphetamine) is a stimulant medication most commonly used to treat ADHD but has been linked to depression both as an off-label treatment for depression and as a cause of depression.
Methamphetamine may be more commonly known by street names like meth, crank and ice. Consumed by injection, snorting or smoking, this illicit synthetic stimulant is composed of amphetamine mixed with a variety of household substances. Drain cleaner, battery acid, paint thinner, or lighter fluid — all highly toxic to the human body — may all be used in the production of methamphetamine.
Amphetamine-induced psychosis may involve delusions, hallucinations and unorganized speech. Amphetamines are psychostimulant drugs, and at low doses, they can lead to increased concentration, alertness and energy. The type of amphetamine used also influences how long the effects last. An amphetamine high from illegal crystal meth can last four to 16 hours.
Treatment for both will involve individual and group psychotherapy sessions, 12-Step program elements, holistic activities, life skills training and health and wellness counseling. Doctors commonly prescribe amphetamines to treat narcolepsy and attention-deficit/hyperactivity disorder (ADHD), especially for teens. However, like any drug, these prescription drugs can be abused when people become dependent on them to function. While people may think they are in control and don’t have a problem, the misuse of prescription drugs, like amphetamines can quickly spiral out of control. Adolescents and adults are more likely to overdose on one or more drugs in order to harm themselves. People who purposefully overdose on medications frequently have mental health conditions.
With the right support, many people who have experienced SUD go on to live happy lives with strong relationships and positive health outcomes. This is not the same as substance dependency — the physical symptoms of tolerance and withdrawal. “Addiction” is the term https://ecosoberhouse.com/ for long-term behavioral, physical, and social changes a person may experience as a result of substance misuse. Everyone’s journey with recovery is different, but asking a healthcare professional, family member, or friend for help is usually the first step.
There was no difference in MA use by UDS in the treatment arm compared with placebo in the extended-release studies [29, 56]. Participants randomised to topiramate returned significantly fewer MA-positive UDS at Week 6, but this result was not sustained throughout the final 4 weeks of the treatment period [55]. A study of atomoxetine (80 mg po OD), a selective norepinephrine (noradrenaline) reuptake inhibitor (SNRI), randomised 69 opioid and ATS-dependent participants to 16 weeks of treatment, assessing ATS use as the primary outcome [58]. The proportion of ATS-negative UDS was higher in the atomoxetine arm compared with placebo, but achieved only a small effect size, while there was no statistically significant difference in days abstinent.